Fundraising September 15, 2024 – October 1, 2024 About fundraising

Volume 18

Diabetes, Obesity and Metabolism

Volume 18

1

Effects of vitamin D 2 or D 3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial

Forouhi, N. G., Menon, R. K., Sharp, S. J., Mannan, N., Timms, P. M., Martineau, A. R., Rickard, A. P., Boucher, B. J., Chowdhury, T. A., Griffiths, C. J., Greenwald, S. E., Griffin, S. J., Hitman, G.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 284 KB

english, 2016

2

Pancreatic β-cell imaging in humans: fiction or option?

Laurent, D., Vinet, L., Lamprianou, S., Daval, M., Filhoulaud, G., Ktorza, A., Wang, H., Sewing, S., Juretschke, H.-P., Glombik, H., Meda, P., Boisgard, R., Nguyen, D. L., Stasiuk, G. J., Long, N. J.,

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 778 KB

english, 2016

3

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 425 KB

english, 2016

4

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)

Terauchi, Y., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 291 KB

english, 2016

5

Use of incretin agents and risk of pancreatic cancer: a population-based cohort study

Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., Driessen, J. H. M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 160 KB

english, 2016

6

Accessory cells for β-cell transplantation

Staels, W., De Groef, S., Heremans, Y., Coppens, V., Van Gassen, N., Leuckx, G., Van de Casteele, M., Van Riet, I., Luttun, A., Heimberg, H., De Leu, N.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 505 KB

english, 2016

7

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes

Katz, L., Manamley, N., Snyder, W. J., Dodds, M., Agafonova, N., Sierra-Johnson, J., Cruz, M., Kaur, P., Mudaliar, S., Raskin, P., Kewalramani, R., Pellacani, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 151 KB

english, 2016

8

Comparison of the pharmacokinetics and pharmacodynamics of dapagliflozin in patients with type 1 versus type 2 diabetes mellitus

Tang, W., Leil, T. A., Johnsson, E., Boulton, D. W., LaCreta, F.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 224 KB

english, 2016

9

Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials

Abbas, A. S., Dehbi, H.-M., Ray, K. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 716 KB

english, 2016

10

Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Diamant, M., Joles, J. A., van Raalte, D. H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 357 KB

english, 2016

11

Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks

Grandy, S., Sternhufvud, C., Ryden, A., Sugg, J., Rohwedder, K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 118 KB

english, 2016

12

Sulphonylurea receptor-1, sulphonylureas and amplification of insulin secretion by Epac activation in β cells

Nenquin, M., Henquin, J.-C.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 231 KB

english, 2016

13

A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells

Saini, C., Petrenko, V., Pulimeno, P., Giovannoni, L., Berney, T., Hebrok, M., Howald, C., Dermitzakis, E. T., Dibner, C.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 967 KB

english, 2016

14

Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes

Pang, J., Chan, D. C., Hamilton, S. J., Tenneti, V. S., Watts, G. F., Barrett, P. H. R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 637 KB

english, 2016

15

Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?

Gallagher, H., Suckling, R. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 145 KB

english, 2016

16

Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase

Economopoulos, K. P., Ward, N. L., Phillips, C. D., Teshager, A., Patel, P., Mohamed, M. M., Hakimian, S., Cox, S. B., Ahmed, R., Moaven, O., Kaliannan, K., Alam, S. N., Haller, J. F., Goldstein, A. M

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.06 MB

english, 2016

17

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Hansen, M., Scheltema, M. J., Sonne, D. P., Hansen, J. S., Sperling, M., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., Knop, F. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 799 KB

english, 2016

18

Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study

Davis, T. M. E., Chubb, S. A. P., Bruce, D. G., Davis, W. A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 399 KB

english, 2016

19

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 31 KB

english, 2016

20

Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes

Erdmann, E., Harding, S., Lam, H., Perez, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 253 KB

english, 2016

21

Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Diamant, M., Pieters-van den Bos, I. C., van Raalte, D. H., Cahen, D. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 736 KB

english, 2016

22

Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials

Seufert, J., Bailey, T., Barkholt Christensen, S., Nauck, M. A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 331 KB

english, 2016

23

Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials

Ard, J., Cannon, A., Lewis, C. E., Lofton, H., Vang Skjøth, T., Stevenin, B., Pi-Sunyer, X.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 496 KB

english, 2016

24

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 90 KB

english, 2016

25

Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor

Darsalia, V., Larsson, M., Lietzau, G., Nathanson, D., Nyström, T., Klein, T., Patrone, C.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 554 KB

english, 2016

26

Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor

DeFronzo, R. A., Chilton, R., Norton, L., Clarke, G., Ryder, R. E. J., Abdul-Ghani, M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 667 KB

english, 2016

27

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 72 KB

english, 2016

28

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score

Woodward, M., Hirakawa, Y., Kengne, A.-P., Matthews, D. R., Zoungas, S., Patel, A., Poulter, N., Grobbee, R., Cooper, M., Jardine, M., Chalmers, J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 196 KB

english, 2016

29

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

Stirban, A. O., Andjelkovic, M., Heise, T., Nosek, L., Fischer, A., Gastaldelli, A., Herz, M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 128 KB

english, 2016

30

Comparison of alogliptin and glipizide for composite endpoint of glycated haemoglobin reduction, no hypoglycaemia and no weight gain in type 2 diabetes mellitus

Del Prato, S., Fleck, P., Wilson, C., Chaudhari, P.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 387 KB

english, 2016

31

Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme

Yu, M., Van Brunt, K., Varnado, O. J., Boye, K. S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 123 KB

english, 2016

32

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 32 KB

english, 2016

33

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 32 KB

english, 2016

34

Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition

Rajeev, S. P., Cuthbertson, D. J., Wilding, J. P. H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 327 KB

english, 2016

35

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Leiter, L. A., Teoh, H., Mosenzon, O., Cahn, A., Hirshberg, B., Stahre, C. A. M., Hoekstra, J. B. L., Alvarsson, M., Im, K., Scirica, B. M., Bhatt, D. L., Raz, I.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 201 KB

english, 2016

36

Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis

Mattishent, K., Loke, Y. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 179 KB

english, 2016

37

Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis

Trasino, S. E., Tang, X.-H., Jessurun, J., Gudas, L. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 2.43 MB

english, 2016

38

Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Cahen, D. L., van Raalte, D. H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 773 KB

english, 2016

39

One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes

Vatier, C., Fetita, S., Boudou, P., Tchankou, C., Deville, L., Riveline, JP., Young, J., Mathivon, L., Travert, F., Morin, D., Cahen, J., Lascols, O., Andreelli, F., Reznik, Y., Mongeois, E., Madelain

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 159 KB

english, 2016

40

Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?

Hodge, R. J., Nunez, D. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 373 KB

english, 2016

41

Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial

Skov, J., Pedersen, M., Holst, J. J., Madsen, B., Goetze, J. P., Rittig, S., Jonassen, T., Frøkiaer, J., Dejgaard, A., Christiansen, J. S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 336 KB

english, 2016

42

Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles

Krentz, A. J., Fujioka, K., Hompesch, M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 232 KB

english, 2016

43

Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study

Rathmann, W., Bongaerts, B., Kostev, K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 113 KB

english, 2016

44

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 32 KB

english, 2016

45

Hypoglycaemia after gastric bypass: mechanisms and treatment

Ritz, P., Vaurs, C., Barigou, M., Hanaire, H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 584 KB

english, 2016

46

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial

Heerspink, H. J. L., Ninomiya, T., Persson, F., Brenner, B. M., Brunel, P., Chaturvedi, N., Desai, A. S., Haffner, S. M., Mcmurray, J. J. V., Solomon, S. D., Pfeffer, M. A., Parving, H.-H., de Zeeuw,

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 317 KB

english, 2016

47

Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas

Deacon, C. F., Lebovitz, H. E.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 236 KB

english, 2016

48

Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes

Ranjan, A., Schmidt, S., Madsbad, S., Holst, J. J., Nørgaard, K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 361 KB

english, 2016

49

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Mikkelsen, K. H., Allin, K. H., Knop, F. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 239 KB

english, 2016

50

Endocannabinoid regulation of β -cell functions: implications for glycaemic control and diabetes

Jourdan, T., Godlewski, G., Kunos, G.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 408 KB

english, 2016

51

Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia

Wan Seman, W. J., Kori, N., Rajoo, S., Othman, H., Mohd Noor, N., Wahab, N. A, Sukor, N., Mustafa, N., Kamaruddin, N. A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 120 KB

english, 2016

52

Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin

Nunez, D. J., Yao, X., Lin, J., Walker, A., Zuo, P., Webster, L., Krug-Gourley, S., Zamek-Gliszczynski, M. J., Gillmor, D. S., Johnson, S. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 645 KB

english, 2016

53

Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. A Focus on Early Phase Clinical Studies. Andrew J. Krentz, Lutz Heinemann, Marcus Hompesch (eds) Springer 2015, ISBN 978-1-4471-4919-4.

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 71 KB

english, 2016

54

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 31 KB

english, 2016

55

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide

Milicevic, Z., Anglin, G., Harper, K., Konrad, R. J., Skrivanek, Z., Glaesner, W., Karanikas, C. A., Mace, K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 256 KB

english, 2016

56

Patterns of self-monitoring of blood glucose in insulin-treated diabetes: analysis of a Scottish population over time

Cameron, D., Harris, F. M., Evans, J. M. M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 94 KB

english, 2016

57

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

Leiter, L. A., Cefalu, W. T., de Bruin, T. W. A., Xu, J., Parikh, S., Johnsson, E., Gause-Nilsson, I.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 308 KB

english, 2016

58

Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications

Dowlat, H. A., Kuhlmann, M. K., Khatami, H., Ampudia-Blasco, F. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 468 KB

english, 2016

59

Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeks

Freude, S., Heise, T., Woerle, H.-J., Jungnik, A., Rauch, T., Hamilton, B., Schölch, C., Huang, F., Graefe-Mody, U.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 472 KB

english, 2016

60

Pharmacokinetics and pharmacodynamics of dapagliflozin in children and adolescents with type 2 diabetes mellitus

Tirucherai, G. S., LaCreta, F., Ismat, F. A., Tang, W., Boulton, D. W.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 204 KB

english, 2016

61

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 424 KB

english, 2016

62

Mixed-effects modelling to quantify the effect of empagliflozin on renal glucose reabsorption in patients with type 2 diabetes

Mondick, J., Riggs, M., Sasaki, T., Sarashina, A., Broedl, U. C., Retlich, S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 456 KB

english, 2016

63

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Rohde, U., Hedbäck, N., Gluud, L. L., Vilsbøll, T., Knop, F. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 415 KB

english, 2016

64

Comparison of the exposure-response relationship of dapagliflozin in adult and paediatric patients with type 2 diabetes mellitus

Parkinson, J., Tang, W., Johansson, C-C., Boulton, D. W., Hamrén, B.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 369 KB

english, 2016

65

Role of E3 ubiquitin ligases in insulin resistance

Yang, X.-D., Xiang, D.-X., Yang, Y.-Y.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 427 KB

english, 2016

66

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 87 KB

english, 2016

67

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers

Heerspink, H. J. L., Johnsson, E., Gause-Nilsson, I., Cain, V. A., Sjöström, C. D.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 350 KB

english, 2016

68

Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?

Prattichizzo, F., Giuliani, A., De Nigris, V., Pujadas, G., Ceka, A., La Sala, L., Genovese, S., Testa, R., Procopio, A. D., Olivieri, F., Ceriello, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 733 KB

english, 2016

69

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 32 KB

english, 2016

70

Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes

Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A., Ahrén, B.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.10 MB

english, 2016

71

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

Schievink, B., Kröpelin, T., Mulder, S., Parving, H.-H., Remuzzi, G., Dwyer, J., Vemer, P., de Zeeuw, D., Lambers Heerspink, H. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 573 KB

english, 2016

72

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

Ilag, L. L., Deeg, M. A., Costigan, T., Hollander, P., Blevins, T. C., Edelman, S. V., Konrad, R. J., Ortmann, R. A., Pollom, R. K., Huster, W. J., Zielonka, J. S., Prince, M. J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 510 KB

english, 2016

73

Sodium-glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low-carbohydrate diet

Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 197 KB

english, 2016

74

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme

Montanya, E., Fonseca, V., Colagiuri, S., Blonde, L., Donsmark, M., Nauck, M. A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 342 KB

english, 2016

75

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

Khunti, K., Nikolajsen, A., Thorsted, B. L., Andersen, M., Davies, M. J., Paul, S. K.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 833 KB

english, 2016

76

Exposure-response analyses of liraglutide 3.0 mg for weight management

Wilding, J. P. H., Overgaard, R. V., Jacobsen, L. V., Jensen, C. B., le Roux, C. W.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 939 KB

english, 2016

77

L-arginine promotes gut hormone release and reduces food intake in rodents

Alamshah, A., McGavigan, A. K., Spreckley, E., Kinsey-Jones, J. S., Amin, A., Tough, I. R., O'Hara, H. C., Moolla, A., Banks, K., France, R., Hyberg, G., Norton, M., Cheong, W., Lehmann, A., Bloom, S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 929 KB

english, 2016

78

Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial

Tepper, S., Shahar, D. R., Geva, D., Ish-Shalom, S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 248 KB

english, 2016

79

Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 analogue, in Latino/Hispanic patients with type 2 diabetes: post hoc analysis of data from four phase III trials

Davidson, J. A., Ørsted, D. D., Campos, C.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 601 KB

english, 2016

80

Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013

Clemens, K. K., Liu, K., Shariff, S., Schernthaner, G., Tangri, N., Garg, A. X.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 493 KB

english, 2016

81

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

Aroda, V. R., Bailey, T. S., Cariou, B., Kumar, S., Leiter, L. A., Raskin, P., Zacho, J., Andersen, T. H., Philis-Tsimikas, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.12 MB

english, 2016

82

Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home

Blauw, H., van Bon, A. C., Koops, R., DeVries, J. H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 638 KB

english, 2016

83

Glucagon orchestrates stress-induced hyperglycaemia

Harp, J. B., Yancopoulos, G. D., Gromada, J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 200 KB

english, 2016

84

Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes

Wolffenbuttel, B. H. R., Van Gaal, L., Durán-Garcia, S., Han, J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 129 KB

english, 2016

85

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26-week, open-label, randomized, active comparator clinical trial

Zang, L., Liu, Y., Geng, J., Luo, Y., Bian, F., Lv, X., Yang, J., Liu, J., Peng, Y., Li, Y., Sun, Y., Bosch-Traberg, H., Mu, Y.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 528 KB

english, 2016

86

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

Rodbard, H. W., Seufert, J., Aggarwal, N., Cao, A., Fung, A., Pfeifer, M., Alba, M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 328 KB

english, 2016

87

A role for exercise after bariatric surgery?

Coen, Paul M., Goodpaster, Bret H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 334 KB

english, 2016

88

Factors associated with failure to achieve a glycated haemoglobin target of

Drake, T. C., Hsu, F.-C., Hire, D., Chen, S.-H., Cohen, R. M., McDuffie, R., Nylen, E., O'Connor, P., Rehman, S., Seaquist, E. R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 123 KB

english, 2016

89

Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels

Blauw, H., Wendl, I., DeVries, J. H., Heise, T., Jax, T.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 441 KB

english, 2016

90

Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial

Davies, M., Sasaki, T., Gross, J. L., Bantwal, G., Ono, Y., Nishida, T., Tojjar, D., Seino, H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 456 KB

english, 2016

91

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Rodbard, H. W., Buse, J. B., Woo, V., Vilsbøll, T., Langbakke, I. H., Kvist, K., Gough, S. C. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 2.18 MB

english, 2016

92

Achieving the composite endpoint of glycated haemoglobin

Dungan, K. M., Raz, I., Skrivanek, Z., Sealls, W., Fahrbach, J. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 345 KB

english, 2016

93

Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans

Oh, J., Chung, H., Park, S.-I., Yi, S. J., Jang, K., Kim, A. H., Yoon, J., Cho, J.-Y., Yoon, S. H., Jang, I.-J., Yu, K.-S., Chung, J.-Y.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 238 KB

english, 2016

94

Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study

Deedwania, P. C., Shepherd, J., Breazna, A., DeMicco, D. A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 296 KB

english, 2016

95

Glucagon increases energy expenditure independently of brown adipose tissue activation in humans

Salem, V., Izzi-Engbeaya, C., Coello, C., Thomas, D. B., Chambers, E. S., Comninos, A. N., Buckley, A., Win, Z., Al-Nahhas, A., Rabiner, E. A., Gunn, R. N., Budge, H., Symonds, M. E., Bloom, S. R., Ta

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 672 KB

english, 2016

96

Similar risk of exercise-related hypoglycaemia for insulin degludec to that for insulin glargine in patients with type 1 diabetes: a randomized cross-over trial

Heise, T., Bain, S. C., Bracken, R. M., Zijlstra, E., Nosek, L., Stender-Petersen, K., Rabøl, R., Rowe, E., Haahr, H. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 190 KB

english, 2016

97

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

Fulcher, G., Matthews, D. R., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Mathieu, C., Woo, V., Wysham, C., Capuano, G., Desai, M., Shaw, W., Vercruysse, F., Meininger, G., Neal, B.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 501 KB

english, 2016

98

Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 917 KB

english, 2016

99

Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin

Freemantle, N., Danchin, N., Calvi-Gries, F., Vincent, M., Home, P. D.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 148 KB

english, 2016

100

Testing the accelerator hypothesis: a new approach to type 1 diabetes prevention (adAPT 1)

Wilkin, T., Greene, S., McCrimmon, R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 95 KB

english, 2016

101

Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study

Odawara, M., Miyagawa, J., Iwamoto, N., Takita, Y., Imaoka, T., Takamura, T.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 270 KB

english, 2016

102

Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial

Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 435 KB

english, 2016

103

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 88 KB

english, 2016

104

Apparent subadditivity of the efficacy of initial combination treatments for type 2 diabetes is largely explained by the impact of baseline HbA1c on efficacy

Polidori, D., Capuano, G., Qiu, R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 570 KB

english, 2016

105

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

Matsuhisa, M., Koyama, M., Cheng, X., Takahashi, Y., Riddle, M. C., Bolli, G. B., Hirose, T.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 339 KB

english, 2016

106

Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine

Hadjiyianni, I., Dahl, D., Lacaya, L. B., Pollom, R. K., Chang, C. L., Ilag, L. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 334 KB

english, 2016

107

Effect of ranolazine on glycaemic control in patients with type 2 diabetes treated with either glimepiride or metformin

Pettus, J., McNabb, B., Eckel, R. H., Skyler, J. S., Dhalla, A., Guan, S., Jochelson, P., Belardinelli, L., Henry, R. H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 649 KB

english, 2016

108

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Hong, S., Park, C.-Y., Han, K. A., Chung, C. H., Ku, B. J., Jang, H. C., Ahn, C. W., Lee, M.-K., Moon, M. K., Son, H. S., Lee, C. B., Cho, Y.-W., Park, S.-W.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 163 KB

english, 2016

109

A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8)

Dungan, K. M., Weitgasser, R., Perez Manghi, F., Pintilei, E., Fahrbach, J. L., Jiang, H. H., Shell, J., Robertson, K. E.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 604 KB

english, 2016

110

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

Aronson, R., Reznik, Y., Conget, I., Castañeda, J. A., Runzis, S., Lee, S. W., Cohen, O.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 356 KB

english, 2016

111

Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once-weekly dulaglutide treatment

Umpierrez, G. E., Pantalone, K. M., Kwan, A. Y. M., Zimmermann, A. G., Zhang, N., Fernández Landó, L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.44 MB

english, 2016

112

Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and

Boustani, M. A., Pittman, I., Yu, M., Thieu, V. T., Varnado, O. J., Juneja, R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 286 KB

english, 2016

113

Cell fate conversion-from the viewpoint of small molecules and lineage specifiers

Zhao, T., Li, Y., Deng, H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 740 KB

english, 2016

114

Three-dimensional pancreas organogenesis models

Grapin-Botton, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 663 KB

english, 2016

115

Shaping and preserving β-cell identity with microRNAs

Dumortier, O., Fabris, G., Van Obberghen, E.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 389 KB

english, 2016

116

Stress-induced adaptive islet cell identity changes

Cigliola, V., Thorel, F., Chera, S., Herrera, P. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 2.08 MB

english, 2016

117

Mechanisms of β-cell functional adaptation to changes in workload

Wortham, M., Sander, M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 943 KB

english, 2016

118

Making β(-like)-cells from exocrine pancreas

Staels, W., De Groef, S., Bussche, L., Leuckx, G., Van de Casteele, M., De Leu, N., Baeyens, L., Heremans, Y., Heimberg, H.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 3.19 MB

english, 2016

119

Mass production of functional human pancreatic β-cells: why and how?

Scharfmann, R., Didiesheim, M., Richards, P., Chandra, V., Oshima, M., Albagli, O.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 572 KB

english, 2016

120

β-Cell adaptation in pregnancy

Baeyens, L., Hindi, S., Sorenson, R. L., German, M. S.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 211 KB

english, 2016

121

Revisiting the immunocytochemical detection of Neurogenin 3 expression in mouse and man

Honoré, C., Rescan, C., Hald, J., McGrath, P. S., Petersen, M. B. K., Hansson, M., Klein, T., Østergaard, S., Wells, J. M., Madsen, O. D.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 2.86 MB

english, 2016

122

β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research

Vieira, A., Courtney, M., Druelle, N., Avolio, F., Napolitano, T., Hadzic, B., Navarro-Sanz, S., Ben-Othman, N., Collombat, P.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 400 KB

english, 2016

123

Impact of Pdx1-associated chromatin modifiers on islet β-cells

Spaeth, J. M., Walker, E. M., Stein, R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 402 KB

english, 2016

124

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 32 KB

english, 2016

125

The role of hepatocyte nuclear factor 1β in disease and development

El-Khairi, R., Vallier, L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 2.85 MB

english, 2016

126

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 426 KB

english, 2016

127

Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice

O'Harte, F. P. M., Ng, M. T., Lynch, A. M., Conlon, J. M., Flatt, P. R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 1.08 MB

english, 2016

128

Effects of ageing and senescence on pancreatic β-cell function

Helman, A., Avrahami, D., Klochendler, A., Glaser, B., Kaestner, K. H., Ben-Porath, I., Dor, Y.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 458 KB

english, 2016

129

Pancreatic β-cell identity in diabetes

Remedi, M. S., Emfinger, C.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 198 KB

english, 2016

130

β-Cell dysfunction in diabetes: a crisis of identity?

Brereton, M. F., Rohm, M., Ashcroft, F. M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 778 KB

english, 2016

131

Mechanisms of adult human β-cell in vitro dedifferentiation and redifferentiation

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 408 KB

english, 2016

132

Novel factors modulating human β-cell proliferation

Shirakawa, J., Kulkarni, R. N.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 358 KB

english, 2016

133

Role of long non-coding RNAs in the determination of β-cell identity

Motterle, A., Sanchez-Parra, C., Regazzi, R.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 350 KB

english, 2016

134

Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes

Cusi, K., Sanyal, A. J., Zhang, S., Hoogwerf, B. J., Chang, A. M., Jacober, S. J., Bue-Valleskey, J. M., Higdon, A. N., Bastyr, E. J., Haupt, A., Hartman, M. L.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 385 KB

english, 2016

135

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 205 KB

english, 2016

136

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials

Rosenstock, Julio, Marre, Michel, Qu, Yongming, Zhang, Shuyu, Bastyr, Edward J., Prince, Melvin J., Chang, Annette M.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 377 KB

english, 2016

137

Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action

Jacober, S. J., Prince, M. J., Beals, J. M., Hartman, M. L., Qu, Y., Linnebjerg, H., Garhyan, P., Haupt, A.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 944 KB

english, 2016

138

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 33 KB

english, 2016

139

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

Mudaliar, S., Henry, R. R., Ciaraldi, T. P., Armstrong, D. A., Burke, P. M., Pettus, J. H., Garhyan, P., Choi, S. L., Knadler, M. P., Lam, E. C. Q., Prince, M. J., Bose, N., Porksen, N. K., Sinha, V.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 394 KB

english, 2016

140

Corrigendum

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

File:

PDF, 79 KB

2016

141

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 431 KB

english, 2016

142

News and Views

Idris, Iskandar

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 208 KB

english, 2016

143

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes

Inagaki, Nobuya, Araki, Eiichi, Oura, Tomonori, Matsui, Akiko, Takeuchi, Masakazu, Tanizawa, Yukio

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 335 KB

english, 2016

144

A randomized clinical trial of basal insulin peglispro vs NPH in insulin-naïve patients with type 2 diabetes: the IMAGINE 6 trial

Grunberger, G., Chen, L., Rodriguez, A., Tinahones, F. J., Jacober, S. J., Bue-Valleskey, J.

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 511 KB

english, 2016

145

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 424 KB

english, 2016

146

Corrigendum

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

File:

PDF, 76 KB

2016

147

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 505 KB

english, 2016

148

Diabetes, Obesity and Metabolism

Journal:

Diabetes, Obesity and Metabolism

Year:

2016

Language:

english

File:

PDF, 489 KB

english, 2016